Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents

American Heart Journal

Volumn 140, Issue 3, 2000, Pages 483-491

  Calver, Alison L ^a   Blows, Lucy J ^a   Harmer, Sue ^a   Dawkins, Keith D ^a   Gray, Huon H ^a   Morgan, John H ^a   Simpson, Iain A ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ADULT; AGED; ARTICLE; CORONARY STENT; DEATH; DEVICE; DRUG COST; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0033832851     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.108825     Document Type: Article

References (29)

1. Audit Of Cardiac Interventional Procedures in the UK 1992-1996
2. Changing incidence and management of abrupt closure following coronary intervention in the new device era
3. Intracoronary stenting for acute and threatened closure complicating transluminal coronary angioplasty
4. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
5. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
6. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators
7. Angiographic follow-up after placement of a self-expanding coronary artery stent
8. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group
9. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
10. Coronary stenting without anticoagulant, without intravascular ultrasound. Results of the French Registry
11. A randomized comparison of anti-platelet and anticoagulant therapy after the placement of coronary-artery stents
12. A clinical trial comparing three antithrombotic drug regimens after coronary stenting (STARS)
13. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study
14. Intracoronary Multi-link stents: Experience in 218 patients using aspirin alone
15. Vessel size and long-term outcome after coronary stent placement
16. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels
17. Ticlopidine an updated review of its pharmacology and therapeutic use in platelet dependent disorders
18. Ticlopidine's mechanism of action on human platelets
19. Ticlopidine and acetylsalicylic acid pre-treatment reduce coagulation and platelet activation during coronary dilatation procedures
20. Ticlopidine and white blood cell disorders. Current Problems in Pharmacovigilance
21. Incidence and clinical course of thrombotic thrombocytopaenic purpura due to ticlopidine following coronary stenting. EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting
22. ADIS new drug profile: Clopidogrel
23. Clopidogrel, a novel antiplatelet and antithrombotic agent
24. ADP receptors on platelets and ADP selective antiaggregating agents
25. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
26. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent throm bosis after coronary stent implantation
27. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
28. Mid-term angiographic oulcome of single versel intracoronary stent placement in diabetic versus non-diabetic patients: A matched comparative study